Altitude illness
- 26 April 2003
- Vol. 326 (7395) , 915-919
- https://doi.org/10.1136/bmj.326.7395.915
Abstract
Summary points: Altitude related illness is rare at altitudes below 2500 metres but is common in travellers to 3500 metres or more. The occurrence is increased by a rapid gain in altitude and reduced by a slow ascent, allowing time for acclimatisation. For most travellers, altitude related illness is an unpleasant but self limiting and benign syndrome, consisting chiefly of headache, anorexia, and nausea. More severe forms of illness including cerebral or pulmonary oedema may occur and may be fatal, particularly if not recognised. The treatment of altitude related illness is to stop further ascent and, if symptoms are severe or getting worse, to descend. Oxygen, drugs, and other treatments for altitude illness should be viewed as adjuncts to aid descent.Citation: Barry, P. W. & Pollard, A. J. (2003). 'Altitude illness', BMJ, 325(7395), 915-919. [Available at http://www.bmj.com]Keywords
This publication has 11 references indexed in Scilit:
- Salmeterol for the Prevention of High-Altitude Pulmonary EdemaNew England Journal of Medicine, 2002
- Children at High Altitude: An International Consensus Statement by an Ad Hoc Committee of the International Society for Mountain Medicine, March 12, 2001High Altitude Medicine & Biology, 2001
- Angiotensin-Converting Enzyme and Genetics at High AltitudeHigh Altitude Medicine & Biology, 2001
- Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic reviewBMJ, 2000
- High Altitude Cerebral Edema and Acute Mountain SicknessPublished by Springer Nature ,1999
- Children in the mountainsBMJ, 1998
- Prediction of acute mountain sicknessBMJ, 1995
- The Causes of Death Among Trekkers in NepalInternational Journal of Sports Medicine, 1992
- Acute mountain sickness susceptibility, fitness and hypoxic ventilatory responseEuropean Respiratory Journal, 1991
- DEATHS DURING MOUNTAINEERING AT EXTREME ALTITUDEThe Lancet, 1988